Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release |
05 March 2013
Intellectual property and trade

As Clock Ticks Toward Trans-Pacific Trade Pact Deadline, U.S. Must End Stall Tactics on Access to Medicines

Press release |
05 March 2013
HIV/AIDS Intellectual property and trade
Malawi

MSF Research Points to Ways to Expand Viral Load Testing in Developing Countries

Press release |
25 February 2013
Intellectual property and trade
South Africa

Africa IP Forum: TAC and MSF ask Minister Rob Davies: “Patent law reform is long overdue, where are your proposals?”

In Congo's rainforest, MSF cured 15.000 pygmies affected by Yaws, a neglected disease, in 3 months (Sept - Oct 2012) using a new therapeutic regime (single dose oral antibiotic) Yaws is a neglected tropical disease caused by a bacterium that affects the skin, bone and cartilage. Lack of resources, it has never been completely eradicated. Humans are the only reservoir of this bacterial infection. A recent discovery that a single-dose of azithromycin (given orally) can cure the disease has raised the prospect Photograph by Lam Duc Hien
Press release
Press release |
24 January 2013
Intellectual property and trade Vaccines

‘Decade of Vaccines’ blueprint ignores high vaccine prices and lacks ambition on better-adapted vaccines

Press release |
08 January 2013
Intellectual property and trade Tuberculosis
South Africa

Some South African TB patients in dire need to get new US approved TB drug

Press release |
03 January 2013
Intellectual property and trade Vaccines
Pakistan

MSF Condemns Targeting of Health Workers in Pakistan

Press release |
31 December 2012
Intellectual property and trade Research and development Tuberculosis

First new tuberculosis drug for 50 years – works on drug-resistant forms of the disease

3 min
Photograph by Siddharth Singh Photograph by Siddharth Singh

2014 Rally in Mumbai for Indian Patent Law.

Press release
Press release |
21 December 2012
HIV/AIDS Intellectual property and trade
India

HIV+ People and MSF Protest Outside Novartis Headquarters In Mumbai Ahead of Verdict in Novartis Vs. India Supreme Court Case

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury